ReviewOncology and therapy2026

Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review.

Marina E Cazzaniga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.